183 related articles for article (PubMed ID: 23371254)
1. The expression of Eg5 predicts a poor outcome for patients with renal cell carcinoma.
Sun D; Lu J; Ding K; Bi D; Niu Z; Cao Q; Zhang J; Ding S
Med Oncol; 2013 Mar; 30(1):476. PubMed ID: 23371254
[TBL] [Abstract][Full Text] [Related]
2. High expression of Mucin13 associates with grimmer postoperative prognosis of patients with non-metastatic clear-cell renal cell carcinoma.
Xu Z; Liu Y; Yang Y; Wang J; Zhang G; Liu Z; Fu H; Wang Z; Liu H; Xu J
Oncotarget; 2017 Jan; 8(5):7548-7558. PubMed ID: 27911274
[TBL] [Abstract][Full Text] [Related]
3. The prognostic value of BAP1, PBRM1, pS6, PTEN, TGase2, PD-L1, CA9, PSMA, and Ki-67 tissue markers in localized renal cell carcinoma: A retrospective study of tissue microarrays using immunohistochemistry.
Kim SH; Park WS; Park EY; Park B; Joo J; Joung JY; Seo HK; Lee KH; Chung J
PLoS One; 2017; 12(6):e0179610. PubMed ID: 28654655
[TBL] [Abstract][Full Text] [Related]
4. Low level of isocitrate dehydrogenase 1 predicts unfavorable postoperative outcomes in patients with clear cell renal cell carcinoma.
Laba P; Wang J; Zhang J
BMC Cancer; 2018 Aug; 18(1):852. PubMed ID: 30153799
[TBL] [Abstract][Full Text] [Related]
5. Feline sarcoma-related protein expression correlates with malignant aggressiveness and poor prognosis in renal cell carcinoma.
Miyata Y; Kanda S; Sakai H; Greer PA
Cancer Sci; 2013 Jun; 104(6):681-6. PubMed ID: 23445469
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of CD44, platelet-derived growth factor receptor alpha, and cyclooxygenase 2 expression in renal cell carcinoma.
Tawfik OW; Kramer B; Shideler B; Danley M; Kimler BF; Holzbeierlein J
Arch Pathol Lab Med; 2007 Feb; 131(2):261-7. PubMed ID: 17284111
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-11 receptor predicts post-operative clinical outcome in patients with early-stage clear-cell renal cell carcinoma.
Pan D; Xu L; Liu H; Zhang W; Zhu Y; Xu J; Gu J
Jpn J Clin Oncol; 2015 Feb; 45(2):202-9. PubMed ID: 25420690
[TBL] [Abstract][Full Text] [Related]
8. Concurrent CD44s and STAT3 expression in human clear cell renal cellular carcinoma and its impact on survival.
Qin J; Yang B; Xu BQ; Smithc A; Xu L; Yuan JL; Li L
Int J Clin Exp Pathol; 2014; 7(6):3235-44. PubMed ID: 25031744
[TBL] [Abstract][Full Text] [Related]
9. Expression of phosphorylated p21-activated kinase 4 is associated with aggressive histologic characteristics and poor prognosis in patients with surgically treated renal cell carcinoma.
Kang HW; Piao XM; Lee HY; Kim K; Seo SP; Ha YS; Kim YU; Kim WT; Kim YJ; Lee SC; Kim WJ; Shin EY; Kim EG; Yun SJ
Investig Clin Urol; 2021 Jul; 62(4):399-407. PubMed ID: 34085786
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of Eg5 predicts unfavorable prognosis in non-muscle invasive bladder urothelial carcinoma.
Ding S; Xing N; Lu J; Zhang H; Nishizawa K; Liu S; Yuan X; Qin Y; Liu Y; Ogawa O; Nishiyama H
Int J Urol; 2011 Jun; 18(6):432-8. PubMed ID: 21449971
[TBL] [Abstract][Full Text] [Related]
11. Expression of dystroglycan correlates with tumor grade and predicts survival in renal cell carcinoma.
Sgambato A; Camerini A; Amoroso D; Genovese G; De Luca F; Cecchi M; Migaldi M; Rettino A; Valsuani C; Tartarelli G; Donati S; Siclari O; Rossi G; Cittadini A
Cancer Biol Ther; 2007 Dec; 6(12):1840-6. PubMed ID: 18087214
[TBL] [Abstract][Full Text] [Related]
12. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
Rabjerg M
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
[TBL] [Abstract][Full Text] [Related]
13. Expression of CD105 cancer stem cell marker in three subtypes of renal cell carcinoma.
Saeednejad Zanjani L; Madjd Z; Abolhasani M; Shariftabrizi A; Rasti A; Asgari M
Cancer Biomark; 2018; 21(4):821-837. PubMed ID: 29286924
[TBL] [Abstract][Full Text] [Related]
14. BUB1B Overexpression Is an Independent Prognostic Marker and Associated with CD44, p53, and PD-L1 in Renal Cell Carcinoma.
Sekino Y; Han X; Kobayashi G; Babasaki T; Miyamoto S; Kobatake K; Kitano H; Ikeda K; Goto K; Inoue S; Hayashi T; Teishima J; Sakamoto N; Sentani K; Oue N; Yasui W; Matsubara A
Oncology; 2021; 99(4):240-250. PubMed ID: 33588420
[TBL] [Abstract][Full Text] [Related]
15. Expression of endothelin 2 and localized clear cell renal cell carcinoma.
Bot BM; Eckel-Passow JE; LeGrand SN; Hilton T; Cheville JC; Igel T; Parker AS
Hum Pathol; 2012 Jun; 43(6):843-9. PubMed ID: 22047647
[TBL] [Abstract][Full Text] [Related]
16. Prognostic implications of the immunohistochemical expression of human kallikreins 5, 6, 10 and 11 in renal cell carcinoma.
Petraki CD; Gregorakis AK; Vaslamatzis MM; Papanastasiou PA; Yousef GM; Levesque MA; Diamandis EP
Tumour Biol; 2006; 27(1):1-7. PubMed ID: 16340244
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of PD-1 and PD-L1 expression in patients with metastatic clear cell renal cell carcinoma.
Ueda K; Suekane S; Kurose H; Chikui K; Nakiri M; Nishihara K; Matsuo M; Kawahara A; Yano H; Igawa T
Urol Oncol; 2018 Nov; 36(11):499.e9-499.e16. PubMed ID: 30131293
[TBL] [Abstract][Full Text] [Related]
18. Klotho suppresses tumor progression via inhibiting PI3K/Akt/GSK3β/Snail signaling in renal cell carcinoma.
Zhu Y; Xu L; Zhang J; Xu W; Liu Y; Yin H; Lv T; An H; Liu L; He H; Zhang H; Liu J; Xu J; Lin Z
Cancer Sci; 2013 Jun; 104(6):663-71. PubMed ID: 23433103
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of Chitinase 3-like 1 and microvessel density predicts metastasis and poor prognosis in clear cell renal cell carcinoma.
Zhang JP; Yuan HX; Kong WT; Liu Y; Lin ZM; Wangs WP; Guo JM
Tumour Biol; 2014 Dec; 35(12):12131-7. PubMed ID: 25142236
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of PDCD4 expression is an independent predictor of poor prognosis in human renal cell carcinoma patients.
Li X; Xin S; Yang D; Li X; He Z; Che X; Wang J; Chen F; Wang X; Song X
J Cancer Res Clin Oncol; 2012 Mar; 138(3):529-35. PubMed ID: 22203471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
